RHOA and neoplasm: For example, overexpression of Δ133p53 in mouse models was reported to be involved in tumour formation through persistent inflammation in an IL-6 dependent manner20,21 as well as in the promotion of the tumour invasion through activation of JAK-STAT and RhoA-ROCK signalling pathways20.